NCT00785291
Clinical Trial Information
Trial Number: NCT00785291 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
Trial Title:
A Randomized Phase III Trial of Weekly Paclitaxel Compared to Weekly Nanoparticle Albumin Bound Nab-paclitaxel or Ixabepilone With or Without Bevacizumab as First-Line Therapy for Locally Recurrent or Metastatic Breast Cancer
Study ID:
CALGB-40502
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00785291-D3 | Dataset NCT00785291-D3-Dataset.csv (c40502_efficacy_all) is one of 3 datasets associated with PubMed ID 26056183. This dataset contains one record per patient enrolled (N=799). Efficacy analyses include only treated patients (N=783); use code treated=1 to identify. Comparisons of paclitaxel vs ixabepilone were limited to only patients randomized to the paclitaxel arm while the ixabepilone arm was open; use code pacsubset=1 to identify. |
| NCT00785291-D2 | The NCT00785291_D2_(c40502_cycles) dataset is one of 3 datasets associated with PubMed ID 26056183. This dataset contains treatment information - one record per cycle patient for those who began treatment. |
| NCT00785291-D1 | The NCT00785291_D1_(c40502_ae) dataset is one of 3 datasets associated with PubMed ID 26056183. This dataset contains one record per adverse event (AE) per patient for those who began treatment. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®